The innovative drug sector began to weaken, and the Kazakh Sanlian fell to a standstill, while Zhongguancun, Zhongsheng Pharmaceutical, Yibai Pharmaceutical, Shijiao Innovation, Sanyuan Gene, and Laimei Pharmaceutical followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.